A Milwaukee father remains at large after his toddler son died from fentanyl exposure, underscoring the lethal reach of synthetic opioids and igniting a storm of public anger over accountability and safety.
At a Glance
- Milwaukee father Demetrius Hubanks charged with child neglect after his 14-month-old son died from fentanyl exposure
- Counterfeit Percocet pills found crushed and accessible in the home
- Wisconsin fentanyl deaths surged 97% from 2019 to 2021
- Similar child overdose cases nationwide have led to lengthy prison sentences
- Public calls intensify for stricter enforcement, prevention, and accountability
Tragedy in Milwaukee
Demetrius Hubanks of Milwaukee faces charges of neglecting a child resulting in death after his 14-month-old son ingested fentanyl-laced counterfeit pills. Authorities say the drugs, crushed and within the toddler’s reach, were discovered after the child was found unresponsive on August 9, 2025. Hubanks admitted to possessing and discarding the fake Percocet pills but has since evaded law enforcement.
Watch now: Child fentanyl deaths and accountability · YouTube
The medical examiner declared the boy brain-dead on August 14, confirming fentanyl toxicity as the cause. On August 20, prosecutors filed charges and issued a warrant, but Hubanks remains missing. His case highlights not only the danger of unsecured synthetic opioids but also the frustration many feel toward gaps in enforcement that allow suspects in fatal child neglect cases to remain at large.
Fentanyl’s Escalating Threat
Fentanyl, a synthetic opioid up to 100 times stronger than morphine, is the leading cause of overdose deaths in Wisconsin and across the United States. According to state health data, fentanyl-related deaths rose by 97% between 2019 and 2021, with counterfeit pills driving much of the increase. Public health officials have repeatedly warned of the risks posed by fentanyl’s spread, yet accidental exposures continue to devastate families.
Similar tragedies have occurred nationwide. In Arizona, a mother received a prison sentence after her child’s fentanyl overdose death, underscoring the severe legal consequences that can follow. In each case, unsecured opioids in the home have proved deadly, particularly to children, and law enforcement continues to flag counterfeit pills as a major source of danger.
Legal and Community Response
Hubanks’s flight has fueled debate over accountability, with calls for stricter penalties and more aggressive enforcement against caregivers whose neglect leads to fentanyl fatalities. Prosecutors in Milwaukee argue that caregivers must face legal consequences when children die from drug exposure, while public health officials emphasize prevention and education to keep dangerous opioids away from homes.
Dr. Paul L. Doering, professor emeritus of pharmacy at the University of Florida, has stressed that even minuscule amounts of fentanyl can be lethal to children. The U.S. Drug Enforcement Administration has echoed this concern, noting that counterfeit pills remain a leading source of accidental exposure. Advocates argue that both law enforcement and community services must work together to prevent repeat tragedies by supporting at-risk families before neglect turns fatal.
Broader Implications
The death of Hubanks’s son has become emblematic of the wider fentanyl epidemic and its effects on American families. Critics say failures in border control, drug enforcement, and child welfare systems have enabled a crisis that places the most vulnerable at risk. Supporters of tougher measures argue that restoring community safety requires a balance of accountability, prevention, and stronger policy enforcement.
As Milwaukee reels from the loss of a young life, the incident highlights a broader national dilemma: how to address a public health emergency that is not only overwhelming emergency services and courts but also eroding family stability and trust in government. The demand for solutions that protect children while holding caregivers accountable is growing louder, and the consequences of inaction are increasingly visible in communities across the country.
Sources
Centers for Disease Control and Prevention
U.S. Drug Enforcement Administration
